Philippe Chamiot-Clerc

Background

About Philippe Chamiot-Clerc

Drug discovery expert, with more than 20 years research experience in academia and pharma industry. Risk manager in charge of Portfolio Risk assessment for develoment projects. In charge of coordination of in vivo plans related to projects (internally and externally). Project, group Head, Core Team member in various therapeutic areas (Neurosciences, diabetes, CV, immuno-inflammation, muscular diseases, opthalmology, pain and urology).with proven records in: Innovative discovery from early stages biology (predictive pharmacological models development) up to entry into clinical development. Successful experience on multiple discovery projects as team leader in a multi-disciplinary and international matrix pharma environment. Interaction as pharmacological expert with the clinical development team to define a development plan (pediatric submission). Involvement as dedicated expert in submission dossier (module 2.4). Management of collaborative projects with industrial or academic partners: partner identification to support business needs, milestones definition, leadership in the planning and coordination of scientific activities in the respect of timelines and budget. Evaluation of external opportunities and participation as expert in strategic working groups (Dry AMD, Dry eye). Laboratory Head in charge of PoC studies, implementation of pre-clinical model, biomarkers identification to support discovery projects. Study director in charge of studies, implementation of pre-clinical model in close relationship with customers, choice of the pharmacological strategy to support pre-clinical development. Co-Management of collaborative and multidisciplinary projects for implementation of electronic labnotebook and IT solution to improve biological results throughput with respect of scientific and ethical constraints. Solid expertise in “Quality in Research”, Best Research Practices and data traceability. Trained as a PhD in cardiovascular pharmacology, with a post-doctoral experience in pulmonary inflammation.